Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Argentina | 47 | 2021 | 231 | 4.230 |
Why?
|
| Hypertension | 24 | 2022 | 8247 | 1.730 |
Why?
|
| Latin America | 16 | 2021 | 352 | 1.370 |
Why?
|
| Exercise | 8 | 2021 | 5319 | 1.360 |
Why?
|
| Chile | 15 | 2020 | 227 | 1.280 |
Why?
|
| Uruguay | 13 | 2019 | 103 | 1.280 |
Why?
|
| Health Promotion | 5 | 2022 | 2180 | 1.160 |
Why?
|
| Diabetes Mellitus | 11 | 2022 | 5415 | 1.100 |
Why?
|
| Cardiovascular Diseases | 25 | 2021 | 14326 | 1.040 |
Why?
|
| Developing Countries | 13 | 2022 | 2720 | 0.800 |
Why?
|
| Food | 2 | 2021 | 724 | 0.760 |
Why?
|
| Prehypertension | 3 | 2016 | 61 | 0.750 |
Why?
|
| Health Behavior | 6 | 2021 | 2600 | 0.740 |
Why?
|
| Urban Health | 1 | 2020 | 539 | 0.650 |
Why?
|
| Home Care Services | 3 | 2020 | 599 | 0.630 |
Why?
|
| Hypercholesterolemia | 3 | 2019 | 1175 | 0.610 |
Why?
|
| Religion | 1 | 2019 | 343 | 0.600 |
Why?
|
| Sodium, Dietary | 2 | 2017 | 413 | 0.600 |
Why?
|
| Obesity, Abdominal | 2 | 2016 | 340 | 0.600 |
Why?
|
| Tobacco | 1 | 2019 | 411 | 0.590 |
Why?
|
| South America | 8 | 2019 | 181 | 0.560 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2017 | 257 | 0.560 |
Why?
|
| Prediabetic State | 2 | 2017 | 466 | 0.560 |
Why?
|
| Food Supply | 1 | 2021 | 461 | 0.560 |
Why?
|
| Physical Exertion | 1 | 2018 | 712 | 0.560 |
Why?
|
| Quality Indicators, Health Care | 3 | 2021 | 1832 | 0.550 |
Why?
|
| Commerce | 1 | 2021 | 589 | 0.540 |
Why?
|
| Motivation | 3 | 2021 | 1893 | 0.530 |
Why?
|
| Program Evaluation | 2 | 2020 | 2529 | 0.510 |
Why?
|
| Prevalence | 22 | 2022 | 14869 | 0.510 |
Why?
|
| Urban Population | 2 | 2019 | 2026 | 0.490 |
Why?
|
| Telemedicine | 7 | 2019 | 2612 | 0.480 |
Why?
|
| Health Services Accessibility | 4 | 2020 | 5010 | 0.480 |
Why?
|
| Cholesterol, LDL | 3 | 2019 | 2371 | 0.470 |
Why?
|
| Public Health | 3 | 2020 | 2374 | 0.470 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 572 | 0.470 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2019 | 806 | 0.470 |
Why?
|
| Cross-Sectional Studies | 22 | 2021 | 23281 | 0.440 |
Why?
|
| Alcohol Drinking | 4 | 2021 | 3884 | 0.440 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 3950 | 0.420 |
Why?
|
| Primary Health Care | 10 | 2021 | 4528 | 0.420 |
Why?
|
| Blood Pressure | 10 | 2021 | 8566 | 0.410 |
Why?
|
| Risk Factors | 35 | 2021 | 70705 | 0.410 |
Why?
|
| Guatemala | 5 | 2022 | 137 | 0.400 |
Why?
|
| Middle Aged | 56 | 2021 | 214868 | 0.390 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1112 | 0.380 |
Why?
|
| Adult | 50 | 2021 | 212128 | 0.360 |
Why?
|
| Poverty | 7 | 2021 | 2577 | 0.360 |
Why?
|
| Sex Factors | 11 | 2019 | 10651 | 0.360 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3130 | 0.350 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2021 | 3033 | 0.340 |
Why?
|
| Body Weight | 1 | 2019 | 4692 | 0.340 |
Why?
|
| Caribbean Region | 4 | 2020 | 172 | 0.340 |
Why?
|
| Humans | 95 | 2022 | 715118 | 0.340 |
Why?
|
| Male | 60 | 2021 | 351080 | 0.320 |
Why?
|
| Quality of Life | 7 | 2020 | 11691 | 0.320 |
Why?
|
| Obesity | 8 | 2021 | 12195 | 0.320 |
Why?
|
| Female | 61 | 2021 | 377328 | 0.310 |
Why?
|
| Air Pollution, Indoor | 3 | 2019 | 882 | 0.300 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3817 | 0.290 |
Why?
|
| Aged | 43 | 2020 | 162672 | 0.290 |
Why?
|
| Qualitative Research | 3 | 2022 | 2535 | 0.260 |
Why?
|
| Antihypertensive Agents | 4 | 2019 | 2064 | 0.250 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2021 | 816 | 0.250 |
Why?
|
| Educational Status | 5 | 2018 | 2332 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3027 | 0.250 |
Why?
|
| Diet | 6 | 2021 | 7583 | 0.250 |
Why?
|
| Pakistan | 4 | 2016 | 298 | 0.240 |
Why?
|
| Health Surveys | 4 | 2019 | 4021 | 0.240 |
Why?
|
| Depression | 2 | 2019 | 7256 | 0.240 |
Why?
|
| Spirometry | 4 | 2021 | 867 | 0.230 |
Why?
|
| Residence Characteristics | 2 | 2021 | 1979 | 0.210 |
Why?
|
| Health Personnel | 4 | 2022 | 3003 | 0.210 |
Why?
|
| Social Class | 3 | 2019 | 1968 | 0.210 |
Why?
|
| Preventive Health Services | 3 | 2017 | 585 | 0.210 |
Why?
|
| Cities | 3 | 2019 | 492 | 0.210 |
Why?
|
| Health Status | 4 | 2018 | 4021 | 0.200 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4465 | 0.190 |
Why?
|
| Cost of Illness | 2 | 2020 | 1840 | 0.180 |
Why?
|
| South Africa | 4 | 2016 | 1560 | 0.180 |
Why?
|
| Peru | 3 | 2016 | 847 | 0.180 |
Why?
|
| Dyslipidemias | 2 | 2016 | 849 | 0.170 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 7722 | 0.170 |
Why?
|
| Marketing | 1 | 2021 | 240 | 0.170 |
Why?
|
| Smoke | 1 | 2019 | 223 | 0.170 |
Why?
|
| India | 4 | 2016 | 2006 | 0.170 |
Why?
|
| Income | 4 | 2020 | 1800 | 0.170 |
Why?
|
| Health Status Disparities | 2 | 2019 | 1722 | 0.160 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 1780 | 0.160 |
Why?
|
| Smoking | 6 | 2018 | 8932 | 0.160 |
Why?
|
| Coronavirus | 1 | 2020 | 151 | 0.160 |
Why?
|
| Education, Pharmacy | 1 | 2017 | 30 | 0.160 |
Why?
|
| Kenya | 2 | 2016 | 563 | 0.160 |
Why?
|
| Diet Surveys | 2 | 2019 | 1175 | 0.150 |
Why?
|
| Health Services Administration | 1 | 2017 | 63 | 0.150 |
Why?
|
| Ambulatory Care | 2 | 2021 | 2773 | 0.150 |
Why?
|
| Chronic Disease | 3 | 2022 | 9022 | 0.150 |
Why?
|
| Cohort Studies | 12 | 2021 | 39804 | 0.150 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 19497 | 0.150 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 812 | 0.150 |
Why?
|
| Secondary Prevention | 2 | 2020 | 1509 | 0.140 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 650 | 0.140 |
Why?
|
| Age Factors | 9 | 2019 | 18789 | 0.140 |
Why?
|
| China | 3 | 2016 | 2272 | 0.140 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2016 | 125 | 0.140 |
Why?
|
| Research Personnel | 1 | 2019 | 517 | 0.130 |
Why?
|
| Geography | 1 | 2017 | 690 | 0.130 |
Why?
|
| Apolipoproteins | 1 | 2017 | 308 | 0.130 |
Why?
|
| Psychological Theory | 1 | 2015 | 169 | 0.130 |
Why?
|
| Risk Assessment | 5 | 2020 | 23510 | 0.130 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 317 | 0.130 |
Why?
|
| Capacity Building | 1 | 2017 | 260 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 5 | 2021 | 5258 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2018 | 1839 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2021 | 4916 | 0.130 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4639 | 0.130 |
Why?
|
| Education | 1 | 2017 | 546 | 0.130 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 4849 | 0.130 |
Why?
|
| Young Adult | 10 | 2022 | 56155 | 0.120 |
Why?
|
| Patient Preference | 2 | 2013 | 858 | 0.120 |
Why?
|
| Biomedical Technology | 1 | 2016 | 221 | 0.120 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2014 | 184 | 0.120 |
Why?
|
| Triglycerides | 2 | 2018 | 2589 | 0.120 |
Why?
|
| Electrocardiography | 5 | 2019 | 6403 | 0.120 |
Why?
|
| Awareness | 1 | 2016 | 599 | 0.110 |
Why?
|
| Health Policy | 3 | 2020 | 2622 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2019 | 3273 | 0.110 |
Why?
|
| Rural Population | 2 | 2020 | 2162 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1420 | 0.110 |
Why?
|
| Workplace | 1 | 2018 | 855 | 0.110 |
Why?
|
| Occupational Health | 1 | 2018 | 838 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3396 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2018 | 767 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1151 | 0.100 |
Why?
|
| Housing | 1 | 2016 | 617 | 0.100 |
Why?
|
| Health Education | 1 | 2018 | 1060 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1502 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 872 | 0.100 |
Why?
|
| Cholesterol | 2 | 2017 | 2896 | 0.100 |
Why?
|
| Government Programs | 2 | 2022 | 267 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1281 | 0.100 |
Why?
|
| Coronary Disease | 2 | 2022 | 6123 | 0.090 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 2341 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2019 | 9968 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2129 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2014 | 474 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 656 | 0.090 |
Why?
|
| Asia, Southeastern | 2 | 2019 | 118 | 0.090 |
Why?
|
| Morbidity | 3 | 2020 | 1701 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2019 | 2631 | 0.090 |
Why?
|
| Logistic Models | 3 | 2019 | 13594 | 0.090 |
Why?
|
| Health Services Needs and Demand | 2 | 2017 | 1434 | 0.090 |
Why?
|
| Cardiology | 1 | 2019 | 1651 | 0.090 |
Why?
|
| Students | 1 | 2018 | 1553 | 0.090 |
Why?
|
| Health | 1 | 2011 | 393 | 0.080 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11402 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 969 | 0.080 |
Why?
|
| Vital Capacity | 2 | 2021 | 912 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2021 | 1610 | 0.080 |
Why?
|
| Mortality | 1 | 2019 | 2794 | 0.080 |
Why?
|
| Dobutamine | 2 | 1997 | 127 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 1562 | 0.080 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2012 | 501 | 0.080 |
Why?
|
| Pandemics | 3 | 2022 | 7212 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3078 | 0.080 |
Why?
|
| Translations | 1 | 2006 | 62 | 0.070 |
Why?
|
| Stroke | 3 | 2016 | 9457 | 0.070 |
Why?
|
| Body Mass Index | 4 | 2016 | 12488 | 0.070 |
Why?
|
| Inflammation | 2 | 2017 | 10085 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 16011 | 0.070 |
Why?
|
| Research Design | 2 | 2018 | 5876 | 0.070 |
Why?
|
| Forced Expiratory Volume | 2 | 2021 | 1725 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2695 | 0.070 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3194 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6075 | 0.070 |
Why?
|
| Adolescent | 6 | 2019 | 85001 | 0.070 |
Why?
|
| Environmental Exposure | 2 | 2018 | 4046 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2020 | 51182 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3707 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 970 | 0.070 |
Why?
|
| Biological Products | 1 | 2013 | 834 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14877 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3364 | 0.060 |
Why?
|
| Time Factors | 7 | 2020 | 41082 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9561 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 10981 | 0.060 |
Why?
|
| Antirheumatic Agents | 1 | 2013 | 1366 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2014 | 2753 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2018 | 3748 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2017 | 6293 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2006 | 761 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2006 | 651 | 0.060 |
Why?
|
| Language | 2 | 2011 | 1246 | 0.050 |
Why?
|
| Administrative Personnel | 1 | 2022 | 180 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3158 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3553 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2016 | 4281 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3276 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2022 | 165 | 0.050 |
Why?
|
| Africa, Eastern | 1 | 2019 | 70 | 0.050 |
Why?
|
| Insulin | 1 | 2015 | 6686 | 0.050 |
Why?
|
| Asthma | 1 | 2018 | 5909 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2018 | 6480 | 0.050 |
Why?
|
| Biomass | 1 | 2019 | 122 | 0.050 |
Why?
|
| Exercise Test | 2 | 1997 | 2116 | 0.050 |
Why?
|
| Life Style | 3 | 2015 | 3708 | 0.040 |
Why?
|
| Colombia | 1 | 2019 | 241 | 0.040 |
Why?
|
| Cause of Death | 2 | 2020 | 3587 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2006 | 1622 | 0.040 |
Why?
|
| Forecasting | 2 | 2019 | 2944 | 0.040 |
Why?
|
| Health Priorities | 1 | 2020 | 387 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 3677 | 0.040 |
Why?
|
| Models, Economic | 1 | 2021 | 723 | 0.040 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 58503 | 0.040 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 2038 | 0.040 |
Why?
|
| Policy Making | 1 | 2020 | 537 | 0.040 |
Why?
|
| Metabolic Equivalent | 1 | 2016 | 14 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2020 | 635 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2017 | 184 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 842 | 0.040 |
Why?
|
| Calibration | 1 | 2019 | 800 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2013 | 2595 | 0.040 |
Why?
|
| Reminder Systems | 1 | 2019 | 388 | 0.040 |
Why?
|
| Incidence | 3 | 2020 | 20596 | 0.040 |
Why?
|
| Self Report | 2 | 2019 | 3420 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 1149 | 0.040 |
Why?
|
| Child | 3 | 2018 | 74147 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1479 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 689 | 0.030 |
Why?
|
| Insurance, Health | 2 | 2019 | 2496 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 432 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2021 | 62186 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2013 | 2973 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2019 | 720 | 0.030 |
Why?
|
| Risk | 2 | 2019 | 9772 | 0.030 |
Why?
|
| Streptokinase | 1 | 1994 | 189 | 0.030 |
Why?
|
| Mentors | 1 | 2019 | 612 | 0.030 |
Why?
|
| Asia | 1 | 2016 | 639 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39285 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 9718 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 657 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 814 | 0.030 |
Why?
|
| Schools | 1 | 2022 | 1373 | 0.030 |
Why?
|
| Occupations | 1 | 2016 | 511 | 0.030 |
Why?
|
| Bangladesh | 1 | 2016 | 794 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1997 | 551 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 1994 | 209 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 1020 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2019 | 2366 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2019 | 863 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2018 | 928 | 0.030 |
Why?
|
| Patient Discharge | 2 | 2014 | 3010 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2927 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 898 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 1997 | 930 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 2014 | 262 | 0.030 |
Why?
|
| Health Resources | 1 | 2018 | 924 | 0.030 |
Why?
|
| Family | 1 | 2022 | 3097 | 0.030 |
Why?
|
| United States | 3 | 2016 | 67666 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 721 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 713 | 0.030 |
Why?
|
| World Health Organization | 1 | 2016 | 1278 | 0.020 |
Why?
|
| Social Support | 1 | 2019 | 2119 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1168 | 0.020 |
Why?
|
| Environment | 1 | 2015 | 1100 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 10123 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 1120 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 985 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 853 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29167 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 5061 | 0.020 |
Why?
|
| Mothers | 1 | 2018 | 2013 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 963 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 2964 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 8269 | 0.020 |
Why?
|
| Health Services Research | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 798 | 0.020 |
Why?
|
| Health Literacy | 1 | 2011 | 391 | 0.020 |
Why?
|
| Air Pollution | 1 | 2018 | 2005 | 0.020 |
Why?
|
| Caregivers | 1 | 2016 | 1905 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2755 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2017 | 2034 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2018 | 2608 | 0.020 |
Why?
|
| Spain | 1 | 2006 | 462 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2018 | 3171 | 0.020 |
Why?
|
| Overweight | 1 | 2016 | 2237 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2182 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 2487 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 2769 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2016 | 41183 | 0.020 |
Why?
|
| Parents | 1 | 2016 | 3160 | 0.010 |
Why?
|
| Mass Screening | 1 | 2019 | 5204 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2008 | 987 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2016 | 2763 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2019 | 72253 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8090 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21789 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2406 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12477 | 0.010 |
Why?
|
| Communication | 1 | 2015 | 3498 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1994 | 2395 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2012 | 1863 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9765 | 0.010 |
Why?
|
| Physicians | 1 | 2018 | 4340 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8043 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2012 | 10531 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3508 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7836 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13302 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7480 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 24645 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 13573 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 27180 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 34497 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 5028 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1994 | 660 | 0.010 |
Why?
|
| Heparin | 1 | 1994 | 1636 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1994 | 4226 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 6538 | 0.000 |
Why?
|
| Acute Disease | 1 | 1994 | 7177 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15258 | 0.000 |
Why?
|
Concepts
(322)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_